These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2976337)

  • 1. [Carbocalcitonin in the treatment of senile osteoporosis and hypercalcemic syndromes].
    Nardini F; Barbagli R; Rossi F
    Clin Ter; 1988 Oct; 127(1):17-25. PubMed ID: 2976337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Profile of a new calcitonin: carbocalcitonin-(Asu1,7) E-CT].
    Nogarin L; Passarella E
    Minerva Med; 1984 Jul; 75(30-31):1809-18. PubMed ID: 6207466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carbocalcitonin, a new synthetic calcitonin: clinical evaluation].
    Pessina R; Fratelli M; Garavaglia C; Der Asvzadurian A
    Chir Ital; 1987 Jun; 39(3):312-7. PubMed ID: 3652325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of the carbocalcitonin + arginine-lysine-lactose combination in senile involutional osteoporosis].
    Abate G; Taormina F; Brillante C; Fraccalaglio L
    Minerva Med; 1994 May; 85(5):253-9. PubMed ID: 8028755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin therapy for bone disease and hypercalcemia.
    Avioli LV
    Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of postmenopausal and senile osteoporosis with synthetic salmon calcitonin. A clinical study].
    Salvini S; Nicolazzo F; Farina P; Martelli G
    Clin Ter; 1987 Jun; 121(6):471-7. PubMed ID: 2973883
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic indications for calcitonin. Experimental examination in some pathologic conditions].
    Perraro F; Piccini F; Donati E
    Folia Endocrinol; 1972 Oct; 25(5):411-23. PubMed ID: 4679243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic application of calcitonin].
    Fujita T
    Nihon Rinsho; 1971 Jul; 29(7):1789-95. PubMed ID: 4948491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Update on paraneoplastic hypercalcemia. Our experience in the treatment of hypercalcemic states of patients with advanced breast carcinoma].
    Grottolo A; Ferrari V; Lazzari R; Mariano MR; Zambruni A; Zaniboni A
    Minerva Med; 1988 Jul; 79(7):527-31. PubMed ID: 3405454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcitonin test].
    Zorzi R; Pescatori E
    Chir Ital; 1986 Jun; 38(3):321-5. PubMed ID: 3791535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with porcine thyrocalcitonin in the treatment of senile osteoporosis].
    Boni A
    Clin Ter; 1980 Aug; 94(3):325-34. PubMed ID: 7449349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic use of calcitonin].
    Laitinen O
    Duodecim; 1973 Jul; 89(21):1401-2. PubMed ID: 4762489
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of senile osteoporosis with porcine extraction calcitonin in paraphysiological doses].
    Vigo P; Girardello R; Soldati L; Favini P; Ortolani S; Polli EE
    Recenti Prog Med; 1979 Jun; 66(6):607-26. PubMed ID: 398571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of a hypercalcemic crisis in a myelomatous patient under chronic hemodialysis. The role of calcitonin].
    Bissoli F; Simonati V; Volpini T; Novi C
    Minerva Nefrol; 1980; 27(2):351-4. PubMed ID: 7219856
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term treatment with thyrocalcitonin in senile osteoporosis: studies with radio-calcium].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):86-8. PubMed ID: 5419776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcitonin: therapeutic update].
    Lacerda AP
    Acta Med Port; 1984; 5(7-8):235-9. PubMed ID: 6516902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term treatment with thyrocalcitonin in senile osteoporosis: metabolic aspects].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):85-6. PubMed ID: 5419775
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.